Shareholder Alert: Sohmer Law Firm Investigating Revance Therapeutics, Inc.

The Sohmer Law Firm announces that it is investigating possible breaches of fiduciary duty claims by the board of directors of Revance Therapeutics, Inc. (NASDAQ:RVNC).

A class action lawsuit was filed against the company alleging that the Registration Statement issued in connection with the company’s June 19, 2014 follow-on public stock offering failed to disclose, among other things, that Revance: (i) had not commenced a Phase 3 clinical trial of RT0001—its lead product under development for the treatment of wrinkles around the eyes—in the first quarter of 2014; and, (ii) did not have the quality or quantity of RT001 to complete a Phase 3 clinical trial. The Sohmer Law Firm is investigating certain claims the company and its shareholders may have against those who signed the Registration Statement.

If you are a current Revance shareholder and want to discuss your legal rights, at no cost and without obligation, please contact Stephen Sohmer by telephone at [phone] or by e-mail at [e-mail].

ATTORNEY ADVERTISING. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160725005853/en/

The Sohmer Law FirmStephen Sohmer, [e-mail]